Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BWX TECHNOLOGIES INC via STRATEGIC MARKETING INNOVATIONS
2026 · third_quarter · Q3
RDTE and Procurement funding for Air Force physical security systems
RDTE and Procurement funding for Air Force physical security systems
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS | 5 | 2025 |
| CODAGENIX | 5 | 2025 |
| TONIX PHARMACEUTICALS | 5 | 2025–2026 |
| AZUL 3D | 4 | 2025 |
| SCIENTIFIC SYSTEMS COMPANY, INC. | 4 | 2026 |
| FEDERAL LABORATORY LLC | 3 | 2025 |
| BWX TECHNOLOGIES INC | 2 | 2026 |
| PREVENT BIOMETRICS | 2 | 2025 |
2026 · third_quarter · RR
RDTE and Procurement funding for Air Force physical security systems
RDTE and Procurement funding for Air Force physical security systems
TONIX PHARMACEUTICALS via STRATEGIC MARKETING INNOVATIONS
2026 · third_quarter · Q3
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCIENTIFIC SYSTEMS COMPANY, INC. via STRATEGIC MARKETING INNOVATIONS
2026 · third_quarter · Q3
Funding support for autonomy and navigation capabilities
Funding support for autonomy and navigation capabilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DREXEL UNIVERSITY via STRATEGIC MARKETING INNOVATIONS
2026 · third_quarter · Q3
Defense appropriations/authorization for DOD R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRAPER via STRATEGIC MARKETING INNOVATIONS
2026 · third_quarter · Q3
Defense-wide materials and microelectronics research and manufacturing in the DOD appropriations bill for FY 2027
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF BRIGHTON MARINE, INC. via STRATEGIC MARKETING INNOVATIONS
2026 · third_quarter · Q3
Policy support for the Uniformed Services Family Health Plan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED FUNCTIONAL FABRICS OF AMERICA via STRATEGIC MARKETING INNOVATIONS
2026 · third_quarter · 3T
Defense manufacturing and appropriations
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
TONIX PHARMACEUTICALS via STRATEGIC MARKETING INNOVATIONS
2026 · second_quarter · Q2
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCIENTIFIC SYSTEMS COMPANY, INC. via STRATEGIC MARKETING INNOVATIONS
2026 · second_quarter · Q2
Funding support for autonomy and navigation capabilities
Funding support for autonomy and navigation capabilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DREXEL UNIVERSITY via STRATEGIC MARKETING INNOVATIONS
2026 · second_quarter · Q2
Defense appropriations/authorization for DOD R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRAPER via STRATEGIC MARKETING INNOVATIONS
2026 · second_quarter · Q2
Defense-wide materials and microelectronics research and manufacturing in the DOD appropriations bill for FY 2027
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF BRIGHTON MARINE, INC. via STRATEGIC MARKETING INNOVATIONS
2026 · second_quarter · Q2
Policy support for the Uniformed Services Family Health Plan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED FUNCTIONAL FABRICS OF AMERICA via STRATEGIC MARKETING INNOVATIONS
2026 · second_quarter · Q2
Defense manufacturing and appropriations
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SCIENTIFIC SYSTEMS COMPANY, INC. via STRATEGIC MARKETING INNOVATIONS
2026 · first_quarter · Q1
Funding support for autonomy and navigation capabilities
Funding support for autonomy and navigation capabilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DREXEL UNIVERSITY via STRATEGIC MARKETING INNOVATIONS
2026 · first_quarter · Q1
Defense appropriations/authorization for DOD R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRAPER via STRATEGIC MARKETING INNOVATIONS
2026 · first_quarter · Q1
Defense-wide materials and microelectronics research and manufacturing in the DOD appropriations bill for FY 2027
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF BRIGHTON MARINE, INC. via STRATEGIC MARKETING INNOVATIONS
2026 · first_quarter · Q1
Policy support for the Uniformed Services Family Health Plan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED FUNCTIONAL FABRICS OF AMERICA via STRATEGIC MARKETING INNOVATIONS
2026 · first_quarter · Q1
Defense manufacturing and appropriations
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SCIENTIFIC SYSTEMS COMPANY, INC. via STRATEGIC MARKETING INNOVATIONS
2026 · first_quarter · RR
Funding support for autonomy and navigation capabilities
TONIX PHARMACEUTICALS via STRATEGIC MARKETING INNOVATIONS
2026 · first_quarter · Q1
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORGING INDUSTRY ASSOCIATION via STRATEGIC MARKETING INNOVATIONS
2026 · first_quarter · 1T
DoD RDT&E Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF BRIGHTON MARINE, INC. via STRATEGIC MARKETING INNOVATIONS
2025 · fourth_quarter · Q4
Policy support for the Uniformed Services Family Health Plan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DREXEL UNIVERSITY via STRATEGIC MARKETING INNOVATIONS
2025 · fourth_quarter · Q4
Defense appropriations/authorization for DOD R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRAPER via STRATEGIC MARKETING INNOVATIONS
2025 · fourth_quarter · Q4
Defense-wide materials and microelectronics research and manufacturing in the DOD appropriations bill for FY 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TONIX PHARMACEUTICALS via STRATEGIC MARKETING INNOVATIONS
2025 · fourth_quarter · Q4
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CODAGENIX via STRATEGIC MARKETING INNOVATIONS
2025 · fourth_quarter · Q4
DOD Support for advanced technology force protection vaccines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS via STRATEGIC MARKETING INNOVATIONS
2025 · fourth_quarter · Q4
Funding for biodefense and pandemic preparedness medical countermeasures
Funding for biodefense and pandemic preparedness medical countermeasures
Funding for biodefense and pandemic preparedness medical countermeasures
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF SCIENTIFIC SYSTEMS COMPANY, INC. via STRATEGIC MARKETING INNOVATIONS
2025 · fourth_quarter · Q4
Funding support for autonomy and navigation capabilities
Funding support for autonomy and navigation capabilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED FUNCTIONAL FABRICS OF AMERICA via STRATEGIC MARKETING INNOVATIONS
2025 · fourth_quarter · Q4
Defense manufacturing and appropriations
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
TONIX PHARMACEUTICALS via STRATEGIC MARKETING INNOVATIONS
2025 · fourth_quarter · RR
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
FORGING INDUSTRY ASSOCIATION via STRATEGIC MARKETING INNOVATIONS
2025 · fourth_quarter · Q4
DoD RDT&E Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DREXEL UNIVERSITY via STRATEGIC MARKETING INNOVATIONS
2025 · third_quarter · Q3
Defense appropriations/authorization for DOD R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRAPER via STRATEGIC MARKETING INNOVATIONS
2025 · third_quarter · Q3
Defense-wide materials and microelectronics research and manufacturing in the DOD appropriations bill for FY 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CODAGENIX via STRATEGIC MARKETING INNOVATIONS
2025 · third_quarter · Q3
DOD Support for advanced technology force protection vaccines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS via STRATEGIC MARKETING INNOVATIONS
2025 · third_quarter · Q3
Funding for biodefense and pandemic preparedness medical countermeasures
Funding for biodefense and pandemic preparedness medical countermeasures
Funding for biodefense and pandemic preparedness medical countermeasures
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF SCIENTIFIC SYSTEMS COMPANY, INC. via STRATEGIC MARKETING INNOVATIONS
2025 · third_quarter · Q3
Funding support for autonomy and navigation capabilities
Funding support for autonomy and navigation capabilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF BRIGHTON MARINE, INC. via STRATEGIC MARKETING INNOVATIONS
2025 · third_quarter · Q3
Policy support for the Uniformed Services Family Health Plan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AZUL 3D via STRATEGIC MARKETING INNOVATIONS
2025 · third_quarter · 3T
Programmatic add to support Army research on the development of advanced manufacturing techniques for optics
Programmatic add to support Army research on the development of advanced manufacturing techniques for optics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED FUNCTIONAL FABRICS OF AMERICA via STRATEGIC MARKETING INNOVATIONS
2025 · third_quarter · Q3
Defense manufacturing and appropriations
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
FORGING INDUSTRY ASSOCIATION via STRATEGIC MARKETING INNOVATIONS
2025 · third_quarter · Q3
DoD RDT&E Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDERAL LABORATORY LLC via STRATEGIC MARKETING INNOVATIONS
2025 · third_quarter · 3T
Increased funding in the House and Senate defense appropriations bills for various issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DREXEL UNIVERSITY via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · Q2
Defense appropriations/authorization for DOD R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRAPER via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · Q2
Defense-wide materials and microelectronics research and manufacturing in the DOD appropriations bill for FY 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CODAGENIX via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · Q2
DOD Support for advanced technology force protection vaccines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · Q2
Funding for biodefense and pandemic preparedness medical countermeasures
Funding for biodefense and pandemic preparedness medical countermeasures
Funding for biodefense and pandemic preparedness medical countermeasures
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF SCIENTIFIC SYSTEMS COMPANY, INC. via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · Q2
Funding support for autonomy and navigation capabilities
Funding support for autonomy and navigation capabilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF BRIGHTON MARINE, INC. via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · Q2
Policy support for the Uniformed Services Family Health Plan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AZUL 3D via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · Q2
Programmatic add to support Army research on the development of advanced manufacturing techniques for optics
Programmatic add to support Army research on the development of advanced manufacturing techniques for optics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED FUNCTIONAL FABRICS OF AMERICA via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · Q2
Defense manufacturing and appropriations
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
PREVENT BIOMETRICS via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · 2T
Defense appropriations for medical technology
Defense appropriations for medical technology
Defense appropriations for medical technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRAPER via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · RR
Defense-wide materials and microelectronics research and manufacturing in the DOD appropriations bill for FY 2026
FORGING INDUSTRY ASSOCIATION via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · Q2
DoD RDT&E Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDERAL LABORATORY LLC via STRATEGIC MARKETING INNOVATIONS
2025 · second_quarter · Q2
Increased funding in the House and Senate defense appropriations bills for various issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF SCIENTIFIC SYSTEMS COMPANY, INC. via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · Q1
Funding support for autonomy and navigation capabilities
Funding support for autonomy and navigation capabilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · Q1
Funding for biodefense and pandemic preparedness medical countermeasures
Funding for biodefense and pandemic preparedness medical countermeasures
Funding for biodefense and pandemic preparedness medical countermeasures
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
CARDINAL POINT PARTNERS, LLC ON BEHALF OF BRIGHTON MARINE, INC. via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · Q1
Policy support for the Uniformed Services Family Health Plan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AZUL 3D via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · Q1
Programmatic add to support Army research on the development of advanced manufacturing techniques for optics
Programmatic add to support Army research on the development of advanced manufacturing techniques for optics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CODAGENIX via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · Q1
DOD Support for advanced technology force protection vaccines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CODAGENIX via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · RA
DOD Support for advanced technology force protection vaccines
AZUL 3D via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · RR
Programmatic add to support Army research on the development of advanced manufacturing techniques for optics
Programmatic add to support Army research on the development of advanced manufacturing techniques for optics
CARDINAL POINT PARTNERS, LLC ON BEHALF OF SCIENTIFIC SYSTEMS COMPANY, INC. via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · RR
Funding support for defense autonomy navigation capabilities Support for Replicator program and related drone programs
Funding support for defense autonomy navigation capabilities Support for Replicator program and related drone programs
CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · RR
Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics
Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics
Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics
CARDINAL POINT PARTNERS, LLC ON BEHALF OF BRIGHTON MARINE, INC. via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · RR
Policy support for the Uniformed Services Family Health Plan
DREXEL UNIVERSITY via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · Q1
Defense appropriations/authorization for DOD R&D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED FUNCTIONAL FABRICS OF AMERICA via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · Q1
Defense manufacturing and appropriations
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
FORGING INDUSTRY ASSOCIATION via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · 1A
DoD RDT&E Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PREVENT BIOMETRICS via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · Q1
Defense appropriations for medical technology
Defense appropriations for medical technology
Defense appropriations for medical technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORGING INDUSTRY ASSOCIATION via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · Q1
DoD RDT&E Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDERAL LABORATORY LLC via STRATEGIC MARKETING INNOVATIONS
2025 · first_quarter · Q1
Increased funding in the House and Senate defense appropriations bills for various issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE